Product image of Dengvaxia (Chimeric Yellow Fever Dengue Virus Serotype 1 (Live, Attenuated), Chimeric Yellow Fever Dengue Virus) supplied by GNH India

Dengvaxia

Active Ingredient:
Chimeric Yellow Fever Dengue Virus Serotype 1 (Live, Attenuated), Chimeric Yellow Fever Dengue Virus
Origin:
EU

Dengvaxia (Chimeric Yellow Fever Dengue Virus Serotype 1 (Live, Attenuated), Chimeric Yellow Fever Dengue Virus)

Dengvaxia is a vaccine designed to prevent dengue fever, a mosquito-borne viral infection. It is administered subcutaneously and is suitable for individuals at risk of exposure to the dengue virus.

Manufacturer / TM Owner

Sanofi Winthrop Industrie

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Dengvaxia is used to protect against dengue fever, which is caused by the dengue virus. This vaccine is typically recommended for individuals living in or traveling to areas where dengue is endemic. It works by stimulating the immune system to produce antibodies against the dengue virus, thereby reducing the risk of infection.

Side Effects

  • Common effects of Dengvaxia may include mild to moderate injection site reactions such as pain, redness, or swelling. Some individuals may also experience general symptoms like headache, fatigue, or muscle pain. These effects are usually temporary and resolve on their own.

Precautions & Warnings

  • Dengvaxia should be administered by healthcare professionals. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Individuals with weakened immune systems should consult their doctor before vaccination.

Avoid Interactions

  • Dengvaxia may interact with other medications or vaccines. It is advisable to discuss your current medications with your healthcare provider before receiving this vaccine. Avoid taking other vaccines simultaneously unless advised by a healthcare professional.

References

Frequently Asked Questions

Dengvaxia is used to prevent dengue fever, a viral infection transmitted by mosquitoes.

Dengvaxia is administered subcutaneously, typically in the upper arm.

Common side effects may include injection site reactions, headache, fatigue, and muscle pain.

Individuals with severe allergies to any component of the vaccine or those with weakened immune systems should consult their healthcare provider before receiving Dengvaxia.

It is important to discuss your current medications with your healthcare provider before receiving Dengvaxia to avoid potential interactions.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Chimeric Yellow Fever Dengue Virus Serotype 1 (Live, Attenuated), Chimeric Yellow Fever Dengue Virus

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT